- 1001. protochordate
- [ ] (UMLS (CSP) C0175966) =Invertebrate
| - 1035. Provenge
- (UMLS (NCI) C1135133) =Pharmacologic Substance; Immunologic Factor ;
|
- 1002. protocol
- [A rule which guides how an activity should be performed. ( NCI )] (UMLS (CSP) C0442711) =Intellectual Product
| - 1036. Proventil
- (UMLS (NCI) C0699770) =Organic Chemical; Pharmacologic Substance
|
- 1003. protocol development
- [ ] (UMLS (CSP) C0872253) =Research Activity ;
| - 1037. Provera
- (UMLS (NCI) C0699702) =Steroid; Pharmacologic Substance
|
- 1004. Protokylol Hydrochloride
- [The hydrochloride salt form of protokylol, a derivative of the beta-adrenergic receptor agonist isoproterenol with bronchodilator activity. Protokylol binds to beta-2 adrenergic receptors in bronchial smooth muscle, thereby activating intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels cause relaxation of bronchial smooth muscle, relieve bronchospasms, improve mucociliary clearance and inhibit the release of mediators of immediate hypersensitivity from cells, especially from mast cells. ( NCI )] (UMLS (NCI) C0770472) =Organic Chemical; Pharmacologic Substance
| - 1038. Provided Patient Education
- [Provided education or training to the patient on appropriate therapy use ( HL7V3.0 )] (UMLS (HL7) C1555297) =Intellectual Product =Other Action Taken;
|
- 1005. proton beam
- [focused beam of accelerated protons; often used in stereotactic radiosurgery and radiation therapy. ( CSP )] (UMLS (CSP) C0729603) =Natural Phenomenon or Process =particle beam;
| - 1039. provider
- [Transaction counts and value totals by Provider Identifier. ( HL7V3.0 )] (UMLS (HL7) C1555587) =Idea or Concept =ActInvoiceAdjudicationPaymentSummaryCode;
ActAdjudicationGroupCode |
- 1006. proton channel
- [ ] (UMLS (CSP) C1537046) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1040. Provider
- [One that makes something available. ( NCI )] (UMLS (NCI) C1138603) =Professional or Occupational Group ;
|
- 1007. proton mass
- [1.6726231 x 10-24 g ( HL7V3.0 )] (UMLS (HL7) C1551076) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 1041. Provider billing
- (UMLS (HL7) C1547605) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Institution bills for provider;
Provider does own billing;
|
- 1008. proton translocation
- [The directed movement of protons (hydrogen ions) into, out of, within or between cells. [GOC:jl] ( GO )] (UMLS (CSP) C1159576) proton transport =Cell Function
| - 1042. Provider does own billing
- (UMLS (HL7) C1549623) =Idea or Concept =Provider billing;
|
- 1009. Protonated
- [addition of hydrogen to a compound. ( CSP )] (UMLS (NCI) C0178812) =Phenomenon or Process ;
=chemical reaction;
| - 1043. Provider initiated episode new/ongoing
- (UMLS (ICPC) C0497121) (Provider initiated episode new/ongoing; kontaktua/arazoa,OLZ agentearen iniziatiba; S-arb initieret episode ny/lobende; Episode nieuw/oud initiat hulpv; KAYNTI HOIDON ANTAJANPYYNNOSTA UUSI/SEURANTA; Episode nouv/en cours init dispens; Episode arztinitiiert neu/Fortsetz; (108); ellato kezdem. uj/gondoz. talalk.; Epis nuovo/in corso su iniz oper; KONTAKT FORARSAKET HELSEARBEIDER; Episod novo/antigo inic prestador; Episodio nuevo/rep inicia prof; VARDGIVARINITIERAD EPISOD NY/FORTGAENDE) Provid init episode new/ongoing; =Health Care Activity =Referrals and Other Reasons for Encounter Component;
|
- 1010. protoplasm
- [The organized colloidal complex of organic and inorganic substances (as proteins and water) that constitutes the living nucleus, cytoplasm, plastids, and mitochondria of the cell. It is composed mainly of nucleic acids, proteins, lipids, carbohydrates, and inorganic salts. ( NCI )] (UMLS (CSP) C0175996) =Cell Component
| - 1044. Provider number
- (UMLS (HL7) C1549739) =Idea or Concept =Identifier type;
|
- 1011. protoplasm motility
- [ ] (UMLS (CSP) C0597306) =Cell Function =cell motility;
| - 1045. Provider Ordered
- (UMLS (HL7) C1548631) =Idea or Concept =Referral reason;
|
- 1012. Protoplasmic Astrocyte
- (UMLS (NCI) C0228089) =Cell
| - 1046. Provider role
- (UMLS (HL7) C1547823) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Primary Care Provider;
Consulting Provider;
Referring Provider;
Referred to Provider;
Admitting;
Attending;
Family Health Care Professional;
Primary Care Provider;
Consulting Provider;
Referring Provider;
Referred to Provider;
|
- 1013. Protoplasmic Astrocytoma
- [A rare variant of diffuse astrocytoma. It is predominantly composed of neoplastic astrocytes showing a small cell body with few, flaccid processes with a low content of glial filaments and scant GFAP expression. This lesion is not well defined and is considered by some authors as an occasional histopathological feature rather than a reproducibly identifiable variant. When occurring in children, this neoplasm may be difficult to separate from pilocytic juvenile astrocytoma. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0334580) =Neoplastic Process
| - 1047. Provider's Office
- [Location where healthcare service was delivered, identified as the healthcare provider's practice office. ( HL7V3.0 )] (UMLS (HL7) C1555596) =Intellectual Product =Outpatient facility;
|
- 1014. protoplast
- [A bacterial cell deprived of its cell wall, for example by growth in an isotonic medium in the presence of antibiotics that block synthesis of the wall peptidoglycan. Alternatively, a plant cell similarly deprived by enzymic treatment. ( NCI )] (UMLS (CSP) C0033731) =Cell ;
| - 1048. Provider_s Office
- (UMLS (HL7) C1548532) =Spatial Concept =Person location type;
|
- 1015. protoplast/spheroplast
- [bacterial, yeast, or fungal cell that results after partial or complete removal of the rigid cell wall, which forms a membrane-bound cell into a spherical shape that is dependent for its integrity on an isotonic or hypertonic medium. ( CSP )] (UMLS (CSP) C0178813) =Cell ;
= ;
| - 1049. provides evidence for
- [Indicates that the target Act provides evidence in support of the action represented by the source Act. The target is not a 'reason' for the source act, but rather gives supporting information on why the source act is an appropriate course of action. Possible targets might be clinical trial results, journal articles, similar successful therapies, etc. Rationale: Provides a mechanism for conveying clinical justification for non-approved or otherwise non-traditional therapies. ( HL7V3.0 )] (UMLS (HL7) C1698593) =Finding ;
=has pertinent information;
|
- 1016. protoplastic membrane
- [ ] (UMLS (CSP) C0598718) =Cell Component ;
| - 1050. provincial/state sales tax
- [Tax levied by the provincial or state jurisdiction such as Provincial Sales Tax ( HL7V3.0 )] (UMLS (HL7) C1555675) =Intellectual Product =ActInvoiceDetailTaxCode;
|
- 1017. protoveratrine
- [Mixtures of closely related hypotensive alkaloids from Veratrum album (Liliaceae). They have been used in the treatment of hypertension but have largely been replaced by drugs with fewer adverse effects. ( MSH )] (UMLS (CSP) C0033737) =Organic Chemical; Pharmacologic Substance =Cevanes;
=CRYPTENAMINE | - 1051. provirus
- [virus genome integrated into the cell genome or into a plasmid in which it replicates; viral DNA is thus passively replicated by the host machinery. ( CSP )] (UMLS (CSP) C0033755) =Nucleic Acid, Nucleoside, or Nucleotide ;
=virus multiplication;
|
- 1018. protozoa
- [highly motile, unicellular eukaryotes, usually predatory or parasitic; movement by cilia, flagella or ameboid motion; may be aquatic or terrestrial. ( CSP )] (UMLS (CSP) C0033739) =Invertebrate ;
=Protista;
=flagellate;
Myxomycophyta;
Apicomplexa;
Ciliophora;
Sarcodina | - 1052. Provisional
- (UMLS (HL7) C1549071) =Idea or Concept =Certificate Status;
|
- 1019. protozoa antigenic variation
- [ ] (UMLS (CSP) C0599841) =Molecular Function
| - 1053. Provocholine
- (UMLS (NCI) C0722884) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
|
- 1020. protozoa disease chemotherapy
- [ ] (UMLS (CSP) C0872255) protozoal disease chemotherapy;
=Therapeutic or Preventive Procedure ;
| - 1054. Prowazekia
- [species of gram negative, aerobic bacteria that is the etiologic agent of epidemic typhus fever acquired through contact with lice, as well as Brill's disease. ( CSP )] (UMLS (CSP) C0035587) =Rickettsia or Chlamydia ;
=Rickettsia;
|
- 1021. protozoa disease pharmacotherapy
- [ ] (UMLS (CSP) C0872373) protozoal disease pharmacotherapy;
viral disease chemotherapy;
viral disease pharmacotherapy;
virus disease chemotherapy;
virus disease pharmacotherapy =Therapeutic or Preventive Procedure ;
| - 1055. PROXIMAL PANCREATECTOMY
- [ ] (UMLS (ICD9CM) C0341072) =Therapeutic or Preventive Procedure
|
- 1022. protozoal antigen
- [any part or derivative of any protozoan that elicits immunity. ( CSP )] (UMLS (CSP) C0003338) =Immunologic Factor
| - 1056. Proximal Phalanx of Finger
- (UMLS (NCI) C0730117) Proximal Phalanx of Hand;
Proximal Phalanx of the Hand;
=Body Part, Organ, or Organ Component |
- 1023. protozoal cyst
- [stage in the life cycle of some protozoans, during which they are enclosed in a protective wall. ( CSP )] (UMLS (CSP) C0597308) =Organism Attribute =morphology;
| - 1057. Proximal Phalanx of Foot
- (UMLS (NCI) C0224020) =Body Part, Organ, or Organ Component
|
- 1024. protozoal genetics
- [heredity, especially the mechanisms of hereditary transmission and the variation of inherited characteristics among a protozoa; the genetic constitution of protozoa. ( CSP )] (UMLS (CSP) C0598870) =Biomedical Occupation or Discipline ;
=Microbial Genetics;
| - 1058. Prozac
- (UMLS (NCI) C0162373) =Organic Chemical; Pharmacologic Substance
|
- 1025. protozoal infection
- [infections with unicellular organisms of the subkingdom Protozoa. ( CSP )] (UMLS (CSP) C0033740) =Disease or Syndrome ;
=parasitic disease;
=amebiasis;
babesiasis;
coccidiosis;
cryptosporidiosis;
giardiasis;
leishmaniasis;
MALARIA;
TOKSOPLASMOOSI;
trypanosomiasis;
protozoal meningoencephalitis;
coccidiosis;
Protozoan Infections, Animal;
Ciliophora Infections;
Sarcomastigophora Infections;
Microsporidiosis;
Tick-Borne Diseases;
Central Nervous System Protozoal Infections | - 1059. prozone phenomenon
- [ ] (UMLS (CSP) C0597773) =Natural Phenomenon or Process ;
|
- 1026. PROTOZOAL INTEST DIS NOS
- [ ] (UMLS (ICD9CM) C0276774) =Disease or Syndrome
| - 1060. PRR - PC/ problem response
- (UMLS (HL7) C1549289) =Health Care Activity =Event Type;
|
- 1027. protozoal meningoencephalitis
- [a rare and often fatal acute, febrile, purulent inflammation of the brain and meninges caused by certain usually free-living soil and water amebas. ( CSP )] (UMLS (CSP) C0597309) =Disease or Syndrome =protozoal infection;
infectious encephalitis | - 1061. PRS (pyrogen releasing substance)
- [ ] (UMLS (CSP) C0598795) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 1028. protozoal toxin
- [toxic substances produced by protozoans. ( CSP )] (UMLS (CSP) C0597310) =Biologically Active Substance =microorganism toxin;
=saxitoxin;
| - 1062. PRUNE BELLY SYNDROME
- [A syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin. ( MSH )] (UMLS (ICD9CM) C0033770) =Congenital Abnormality ;
=Abnormalities, Multiple;
|
- 1029. protozoal vaccine
- [vaccine administered for the prevention or treatment of infectious protozoan disease. ( CSP )] (UMLS (CSP) C0080067) =Pharmacologic Substance; Immunologic Factor =[IM100] VACCINES;
=malaria;
| - 1063. PRURIGO
- [A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. (From Dorland, 27th ed) ( MSH )] (UMLS (ICD9CM) C0033771) =Disease or Syndrome ;
=Cutaneous Disorder;
|
- 1030. PROTRIPTYLINE
- [Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation. ( MSH )] (UMLS (NCI) C0033743) =Organic Chemical; Pharmacologic Substance =[CN601] TRICYCLIC ANTIDEPRESSANTS;
Dibenzocycloheptenes =5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-, Hydrochloride | - 1064. Pruritis
- [intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.(CSP)] (UMLS (ICPC) C0033774) (Pruritis; HAZNAHIA, ERRASUMINA (ESKL. UZKIGENITALA D05); Hudkloe irritation (ex D05 X16); Pruritus/jeuk (ex D05 X16); KUTINA (PPL. D05 X16); Prurit (SF D05 X16); Pruritus/Juckreiz (ex D05 X16); iktzutz; viszketes (kiv. D05, X16); Prurito(escl D05 X16); HUDKLOE/IRRITASJON EKS X16; Prurido/ardor (excl D05 X16) ; Prurito/escozor piel(ex D05 X16); KLADA/PRURITUS (EXKL D05 X16)) Pruritis (excl D05 X16); Pruritis (excluding D05 X16) =Disease or Syndrome ;
=Cutaneous Disorder; Skin Manifestations; Symptoms and Complaints Component; Integument =HAZNAHI PERIANALA; Pruritus Vulvae; DERMATOPHYTOSIS OF FOOT |
- 1031. protruded disk
- [ ] (UMLS (CSP) C0599460) =Disease or Syndrome
| - 1065. Pruritus and related conditions
- [ ] (UMLS (ICD9CM) C0157724) =Sign or Symptom
|
- 1032. PROTRUSIO ACETAB-UNSPEC
- [ ] (UMLS (ICD9CM) C0375491) =Anatomical Abnormality
| - 1066. Pruritus of genital organs
- (UMLS (ICD9CM) C0033777) =Sign or Symptom ;
|
- 1033. PROTRUSIO ACETABULI NOS
- [ ] (UMLS (ICD9CM) C0158129) =Disease or Syndrome ;
| - 1067. Pruritus Vulvae
- [Intense itching of the external female genitals. ( MSH )] (UMLS (NCI) C0033778) =Sign or Symptom ;
=HAZNAHIA, ERRASUMINA (ESKL. UZKIGENITALA D05);
Vulvar Disease |
- 1034. Protrusion
- (UMLS (NCI) C0333056) =Anatomical Abnormality ;
| - 1068. Prussian blue stain
- [Stain, Prussian blue ( HL7V3.0 )] (UMLS (HL7) C1294004) =Laboratory Procedure =ObservationMethod;
|
home
